Table 4

Comparison of mean serum 25(OH)D levels at baseline and first follow-up stratified by top 5 cancer sites (N = 799)

Site of tumor

Baseline

Mean 25(OH)D in ng/mL (SD)

Follow-up

Mean 25(OH)D in ng/mL (SD)

Paired t-test

p-value


All Cancers (n = 799)

19.1 (7.5)

36.2 (17.1)

< 0.001


Breast (n = 182)

19.7 (8.0)

37.6 (16.8)

< 0.001


Lung (n = 120)

18.4 (7.3)

41.1 (18.9)

< 0.001


Pancreas (n = 60)

16.2 (7.7)

30.8 (14.2)

< 0.001


Colorectal (n = 90)

18.7 (7.7)

31.9 (16.2)

< 0.001


Prostate (n = 60)

20.2 (6.9)

42.1 (15.9)

< 0.001


Others (n = 287)

19.5 (7.1)

34.6 (16.8)

< 0.001


SD = Standard Deviation

Vashi et al. Nutrition Journal 2010 9:60   doi:10.1186/1475-2891-9-60

Open Data